Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Spanish reimbursement system

Legal developments in product liability

With restrictive legislation and recent landmark cases, the medical industry is under increasing legal pressure

Gilead Sciences

Gilead, Merck get CHMP backing for new hep C combinations

Approval of Epclusa and Zepatier will see the pan-genotypic drugs compete for market share

EU flag

Second Remicade biosimilar given green light in Europe

Samsung Bioepis’ Flixabi provides another lower-cost treatment option

The role of empathy in the design of products and services

Peter Timmer of Blue Latitude Health talks through what it means to design with empathy for the customer, and why it produces better products and services.

Blue Latitude Health

ClinTec appoints regional manager for Spain and Portugal

Carlos Palacios joins the contract research organisation

Deal Watch April 2016

“This is the way the world ends, not with a bang but a whimper”And so it was with Pfizer’s acquisition of Allergan. The big splash from the 3rd biggest corporate...

- PMLiVE

FDA gives green light for opioid addiction implant

Titan and Braeburn's Probuphine is first implant of its kind to win US approval

- PMLiVE

Medtronic and Qualcomm to work on new diabetes sensors

Will initially collaborate on a single-use wireless continuous glucose monitoring system

National Institute for Health and Care Excellence NICE logo

NICE gives green light to Sanofi’s Jevtana for prostate cancer

Undisclosed discount for NHS encourages U-turn to back the chemotherapy drug

Sanofi reception

FDA panel backs Sanofi’s insulin/GLP-1 agonist combo

iGlarLixi secures endorsement despite concern over its dosing and delivery device

Hansa Medical strengthens management team

Henk Doude van Troostwijk becomes vice president, commercial operations

Eli Lilly HQ

Lilly planning 20 new launches by 2023

Will focus on diabetes, immunology, oncology, neurodegeneration and pain

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links